← Evidence map

ReviewJournal of clinical medicine2026

Hyperthermic Intravesical Chemotherapy as a Bladder-Sparing Alternative to BCG in the Management of Non-Muscle-Invasive Bladder Cancer: A Systematic Review of Oncological Outcomes in the Era of BCG Shortage.

Alexei Croitor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Hyperthermic Intravesical Chemotherapy as a Bladder-Sparing Alternative to BCG in the Management of Non-Muscle-Invasive Bladder Cancer: A Systematic Review of Oncological Outcomes in the Era of BCG Shortage. | OpenQuestion